Company / Operating Cash Flow
LeMaitre Vascular Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$81.3M
FY2025
5-year range
$14.2M / $81.3M
FY2021-FY2025
Trend
+84.1%
vs FY2024
Sector context
#112 of 164
Health Care
What the data says
At $81M, LeMaitre Vascular's operating cash flow ranks #112 of 164 in the Health Care sector. Operating Cash Flow has increased for 4 consecutive years, from $14M in FY2021 to $81M in FY2025.
Based on SEC 10-K filings.
$81M in FY2025 with a 5-year CAGR of +33.0%.
Improved from $37M to $81M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- +32.7%
- 5-Year CAGR
- +33.0%
- 10-Year CAGR
- -
Sector benchmark
#112 of 164 in Health CareTop 68% of 164This company $81.3M Sector average $1.0B
▼
-92.2% below sector average
Key checks
Key Insights
- LeMaitre Vascular's operating cash flow has grown for 4 consecutive years.
- 5-year CAGR of +33.0%, indicating consistent growth.
- In FY2025, operating cash flow increased 84.1% year-over-year.
- Ranks #112 out of 164 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 20.0%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $81.3M | +84.1% |
| FY2024 | $44.1M | +20.1% |
| FY2023 | $36.8M | +5.6% |
| FY2022 | $34.8M | +145.4% |
| FY2021 | $14.2M | -27.3% |
| FY2020 | $19.5M | -14.7% |
| FY2019 | $22.9M | +35.3% |
| FY2018 | $16.9M | +47.7% |
| FY2017 | $11.4M | -32.3% |
| FY2016 | $16.9M | +213.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026